Cargando…

Elevated homocysteine level in first-episode schizophrenia patients—the relevance of family history of schizophrenia and lifetime diagnosis of cannabis abuse

Accumulating evidence indicates that elevated homocysteine (Hcy) level occurs in first-episode schizophrenia (FES) patients. We included 56 FES patients and 53 healthy controls (HC). Plasma level of Hcy was significantly higher in FES patients than HC (p = 0.044). In addition, plasma levels of high-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Misiak, Blazej, Frydecka, Dorota, Slezak, Ryszard, Piotrowski, Patryk, Kiejna, Andrzej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125810/ https://www.ncbi.nlm.nih.gov/pubmed/24682777 http://dx.doi.org/10.1007/s11011-014-9534-3

Ejemplares similares

Erratum to: Elevated homocysteine level in first-episode schizophrenia patients—the relevance of family history of schizophrenia and lifetime diagnosis of cannabis abuse
por: Misiak, Blazej, et al.
Publicado: (2014)

Genetic Variation in One-Carbon Metabolism and Changes in Metabolic Parameters in First-Episode Schizophrenia Patients
por: Misiak, Błażej, et al.
Publicado: (2016)

Effects of second-generation antipsychotics on selected markers of one-carbon metabolism and metabolic syndrome components in first-episode schizophrenia patients
por: Misiak, Błażej, et al.
Publicado: (2014)

Predictors of vocational status in schizophrenia patients – Results from the Polish nationwide survey
por: Kiejna, Andrzej, et al.
Publicado: (2015)

Money matters: does the reimbursement policy for second-generation antipsychotics influence the number of recorded schizophrenia patients and the burden of stigmatization?
por: Kiejna, Andrzej, et al.
Publicado: (2013)

Homocysteine levels in schizophrenia and affective disorders—focus on cognition
por: Moustafa, Ahmed A., et al.
Publicado: (2014)

Corrigendum: Homocysteine levels in schizophrenia and affective disorders—focus on cognition
por: Moustafa, Ahmed A., et al.
Publicado: (2015)

Sex differences in TGFB-β signaling with respect to age of onset and cognitive functioning in schizophrenia
por: Frydecka, Dorota, et al.
Publicado: (2015)

Interleukin-6: the missing element of the neurocognitive deterioration in schizophrenia? The focus on genetic underpinnings, cognitive impairment and clinical manifestation
por: Frydecka, Dorota, et al.
Publicado: (2014)

Genetic variants in transforming growth factor-β gene (TGFB1) affect susceptibility to schizophrenia
por: Frydecka, Dorota, et al.
Publicado: (2013)

Copy Number Variations and Schizophrenia
por: Szecówka, Kamila, et al.
Publicado: (2022)

Confirmation Bias in the Course of Instructed Reinforcement Learning in Schizophrenia-Spectrum Disorders
por: Frydecka, Dorota, et al.
Publicado: (2022)

The Role of Dopaminergic Genes in Probabilistic Reinforcement Learning in Schizophrenia Spectrum Disorders
por: Frydecka, Dorota, et al.
Publicado: (2021)

Editorial: Endophenotypes for Schizophrenia and Mood Disorders: Implications from Genetic, Biochemical, Cognitive, Behavioral, and Neuroimaging Studies
por: Misiak, Błażej, et al.
Publicado: (2016)

Cortisol and dehydroepiandrosterone sulfate in patients with schizophrenia spectrum disorders with respect to cognitive performance
por: Misiak, Błażej, et al.
Publicado: (2021)

Assessment of interrelationships between cognitive performance, symptomatic manifestation and social functioning in the acute and clinical stability phase of schizophrenia: insights from a network analysis
por: Misiak, Błażej, et al.
Publicado: (2023)

Assessment of the Association Between Cigarette Smoking and Cognitive Performance in Patients With Schizophrenia-Spectrum Disorders: A Case-Control Study
por: Stramecki, Filip, et al.
Publicado: (2018)

Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse
por: Wobrock, Thomas, et al.
Publicado: (2009)

Metabolic Dysregulation and Psychosocial Stress in Patients with Schizophrenia Spectrum Disorders: A Case-Control Study
por: Misiak, Błażej, et al.
Publicado: (2020)

The interplay between childhood trauma, cognitive biases, and cannabis use on the risk of psychosis in nonclinical young adults in Poland
por: Frydecka, Dorota, et al.
Publicado: (2020)

Interactions Between Variation in Candidate Genes and Environmental Factors in the Etiology of Schizophrenia and Bipolar Disorder: a Systematic Review
por: Misiak, Błażej, et al.
Publicado: (2017)

The Deficit Schizophrenia Subtype Is Associated with Low Adherence to the Mediterranean Diet: Findings from a Case–Control Study
por: Kowalski, Krzysztof, et al.
Publicado: (2022)

Decreased Serum Oxytocin and Increased Homocysteine in First-Episode Schizophrenia Patients
por: Liu, Yong, et al.
Publicado: (2019)

Adverse Childhood Experiences and Methylation of the FKBP5 Gene in Patients with Psychotic Disorders
por: Misiak, Błażej, et al.
Publicado: (2020)

Disease-relevant autoantibodies in first episode schizophrenia
por: Zandi, Michael S., et al.
Publicado: (2010)

Impairments of working memory in schizophrenia and bipolar disorder: the effect of history of psychotic symptoms and different aspects of cognitive task demands
por: Frydecka, Dorota, et al.
Publicado: (2014)

Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence
por: Malchow, Berend, et al.
Publicado: (2012)

Editorial: Schizophrenia: Human and Animal Studies
por: Moustafa, Ahmed A., et al.
Publicado: (2016)

The Role of Cytokines in the Pathogenesis of Schizophrenia
por: Dawidowski, Bartosz, et al.
Publicado: (2021)

Editorial: Peripheral Markers of Immune Response in Major Psychiatric Disorders: Where Are We Now and Where Do We Want to Be?
por: Misiak, Błazej, et al.
Publicado: (2019)

Metabolic Parameters in Patients with Prader-Willi Syndrome and DiGeorge Syndrome with Respect to Psychopathological Manifestation
por: Krefft, Maja, et al.
Publicado: (2020)

Association of sociodemographic, proximal, and distal clinical factors with current suicidal ideation: Findings from a nonclinical sample of young adults
por: Misiak, Błażej, et al.
Publicado: (2023)

Is Cannabis Abuse Is Related with Personality Factors, Aggression, Impulsivity And Sensation Seeking In Patients With Schizophrenia
por: Kumar, Gyanendra, et al.
Publicado: (2022)

Homocysteine Levels in Patients with Schizophrenia on Clozapine Monotherapy
por: Wysokiński, Adam, et al.
Publicado: (2013)

Cannabis Use and Cognition in Schizophrenia
por: Løberg, Else-Marie, et al.
Publicado: (2009)

The Neural Correlates of Mental Rotation Abilities in Cannabis-Abusing Patients with Schizophrenia: An fMRI Study
por: Potvin, Stéphane, et al.
Publicado: (2013)

Increased serum homocysteine in first episode and drug-naïve individuals with schizophrenia: sex differences and correlations with clinical symptoms
por: Yang, Xu, et al.
Publicado: (2022)

T86. RELEVANCE OF CANNABIS USE AS A PREDICTOR OF CLINICAL OUTCOME IN FIRST-EPISODE SCHIZOPHRENIA SPECTRUM DISORDER PATIENTS OVER 24 MONTHS OF TREATMENT
por: Scheffler, Frederika, et al.
Publicado: (2020)

The Effect of Cannabis Use and Cognitive Reserve on Age at Onset and Psychosis Outcomes in First-Episode Schizophrenia
por: Leeson, Verity C., et al.
Publicado: (2012)

The Association between Lifestyle Choices and Schizophrenia Symptoms
por: Kalinowska, Sylwia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i9rhuajohudpb3dnhbjupeb3ko